JENNIFER POTTS: Open Payments
NPI 1932975018 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,549 in 79 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,762 · 2025 $1,549
Food & beverage: $1,549
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $338 |
| AstraZeneca Pharmaceuticals LP | 8 | $211 |
| Axsome Therapeutics, Inc. | 7 | $148 |
| ABBVIE INC. | 12 | $139 |
| Dexcom, Inc. | 5 | $102 |
| Lilly USA, LLC | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| PFIZER INC. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
Products named: Wegovy, Auvelity, VRAYLAR, FARXIGA, Dexcom G6 Transmitter, LEQVIO, NURTEC ODT, JARDIANCE.
Industry payments across FL — which companies pay providers there.
